In Person

How to Scale without Getting Scathed

May 22, 2019
Event details
May 22, 2019
11:00 am
San Diego, CA

Event summary

You’ve got proof-of-concept, validation data and have secured a sizeable round of funding to finally give you some breathing room - The next steps along the path from innovation to established company are crucial and could mean the difference between game-changing growth or derailment. Join Johnson & Johnson Innovation, JLABS and a panel of leaders to delve into strategies to support your company’s growth as it enters the scaling phase.

Topics include: 
  • Keeping the balance in check (product/services, team, financials, business model)
  • Financial planning
  • Growing your team
  • Choosing the right people, investors, partners
  • Stock/equity allocation
  • Importance of maintaining company culture
  • Management 
  • Structures: Dividing labor and leadership, standardizing workflows
  • Accountability: Advisory board, outside


Presenters

Karen Anderson, JD, MBA – Partner, Cooley

Jeff Friedman, PhD – COO, DTx Pharma (moderator)

Casey Hayes, CPA – Assurance Partner, Ernst & Young

Ciara Kennedy, PhD, MBA – CEO, Amplyx Pharmaceuticals

Vijay Murthy, PhD – Principal, Johnson & Johnson Innovation - JJDC

 

Event details and registration

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.